Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank79
3Y CAGR-17.0%
5Y CAGR-2.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-17.0%/yr
vs +41.8%/yr prior
5Y CAGR
-2.0%/yr
Recent deceleration
Acceleration
-58.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $133.82M | +15.5% |
| 2024 | $115.85M | -2.1% |
| 2023 | $118.37M | -49.5% |
| 2022 | $234.19M | +97.3% |
| 2021 | $118.72M | -19.6% |
| 2020 | $147.70M | +22.9% |
| 2019 | $120.18M | +107.4% |
| 2018 | $57.94M | -65.7% |
| 2017 | $168.74M | +152.7% |
| 2016 | $66.76M | - |